Medical Alley’s contributions to modern cardiology are undeniable. From the pre-PCR days of open-heart surgery performed via hypothermia and the Lillehei-DeWall bubble oxygenator to modern techniques and tools like percutaneous catheterizations of the heart and the Amplatzer Septal and Cribriform Occluders, Minnesota has proven fertile ground for life-saving developments in cardiology.
But the Medical Alley’s contributions are more than just historical hallmarks. Today, no one pushes valve and catheter technology further than Medical Alley: No state has more original premarket approvals (PMAs) for catheters or granted patents for catheters and valves per capita than Minnesota has.
That innovative work is on display at EuroPCR 2018, as 11 Medical Alley members are showing off their latest work. Companies like Medtronic, Abbott, Boston Scientific, 4C Medical, and Philips as well as organizations like Mayo Clinic and Minneapolis Heart Institute are presenting key findings from recent trials, hosting training seminars, leading panels, and presenting posters at the world’s leading PCR conference, proving once again that the future of healthcare happens in Medical Alley.
As the world gathers in Paris to celebrate the accomplishments of a field credited with saving so many lives and to look forward to the innovations that will save so many more, Medical Alley once again shows why it is the global epicenter of health innovation and care.
